Takeda Pharmaceutical Co Ltd 20-F for FY2021
Takeda Pharmaceutical Co Ltd (TAK)
20-F
2021-06-29
For: 2021-03-31
View Original
Added on
April 07, 2026
About this 20-F
Takeda Pharmaceutical Co Ltd filed this 20-F on June 29, 2021, covering the fiscal year ended March 31, 2021 (FY2021).
Headline figures
Fiscal year ended March 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 3.2T JPY
- down 2.8% from 3.29T JPY a year earlier
- Net income
- 376.01B JPY
- up 749.9% from net income of 44.24B JPY a year earlier
- Diluted EPS
- 238.96 JPY
- up 745.9% from 28.25 JPY a year earlier